Clinical Trial

Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The investigators are evaluating postoperative outcomes in patients undergoing hip replacement surgery performed with either spinal or general anesthesia, who also receive a suprainguinal fascia iliaca block using either perineural ropivacaine alone or ropivacaine combined with dexmedetomidine.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-31.
Trial Details
NCT Number NCT07316166
Lead Sponsor Rhode Island Hospital
Conditions Postoperative Pain Management
Enrollment 120 participants
Start Date 2026-01-20
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-25